Pure Global

ATELLICA CH DIAZO DIRECT BILIRUBIN (D_DBIL); ATELLICA CH DIAZO TOTAL BILIRUBIN (D_TBIL). - DIGEMID Registration DMDIV5659E

Access comprehensive regulatory information for ATELLICA CH DIAZO DIRECT BILIRUBIN (D_DBIL); ATELLICA CH DIAZO TOTAL BILIRUBIN (D_TBIL). in the Peru medical device market through Pure Global AI's free database. This medical device is registered under DIGEMID ID DMDIV5659E and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS INC. The device was registered on July 24, 2024.

This page provides complete registration details including product type (IN VITRO MEDICAL DEVICE), manufacturer information, authorized representative details, and regulatory compliance data from the official Peru DIGEMID medical device database. Pure Global AI offers free access to Peru's complete medical device registry.

Free Database
Powered by Pure Global AI
DIGEMID Official Data
DMDIV5659E
ATELLICA CH DIAZO DIRECT BILIRUBIN (D_DBIL); ATELLICA CH DIAZO TOTAL BILIRUBIN (D_TBIL).
DIGEMID ID: DMDIV5659E
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Device Classification
Product Type
IN VITRO MEDICAL DEVICE
Registration Information
Analysis ID
DMDIV5659E
Registration Date
July 24, 2024
Expiration Date
July 24, 2029
Creation Date
February 17, 2025
Authorized Representative